UK legislation on analgesic packs: before and after study of long term effect on poisonings

Abstract Objective To evaluate the long term effect of legislation limiting the size of packs of analgesics sold over the counter. Design Before and after study. Setting Suicides in England and Wales, data from six liver units in England and Scotland and five general hospitals in England, and UK dat...

Full description

Saved in:
Bibliographic Details
Published inBMJ Vol. 329; no. 7474; pp. 1076 - 1079
Main Authors Hawton, Keith, Simkin, Sue, Deeks, Jonathan, Cooper, Jayne, Johnston, Amy, Waters, Keith, Arundel, Morag, Bernal, William, Gunson, Bridget, Hudson, Mark, Suri, Deepak, Simpson, Kenneth
Format Journal Article
LanguageEnglish
Published London British Medical Journal Publishing Group 06.11.2004
British Medical Association
BMJ Publishing Group LTD
BMJ Publishing Group Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Objective To evaluate the long term effect of legislation limiting the size of packs of analgesics sold over the counter. Design Before and after study. Setting Suicides in England and Wales, data from six liver units in England and Scotland and five general hospitals in England, and UK data on sales of analgesics, between September 1993 and September 2002. Data sources Office for National Statistics; six liver units in England and Scotland; monitoring systems in general hospitals in Oxford, Manchester, and Derby; and Intercontinental Medical Statistics Health UK. Main outcome measures Deaths by suicidal overdose with paracetamol, salicylates, or ibuprofen; numbers of patients admitted to liver units, listed for liver transplant, and undergoing transplantations for paracetamol induced hepatotoxicity; non-fatal self poisonings with analgesics and numbers of tablets taken; and sales figures for analgesics. Results Suicidal deaths from paracetamol and salicylates were reduced by 22% (95% confidence interval 11% to 32%) in the year after the change in legislation on 16 September 1998, and this reduction persisted in the next two years. Liver unit admissions and liver transplants for paracetamol induced hepatotoxicity were reduced by around 30% in the four years after the legislation. Numbers of paracetamol and salicylate tablets in non-fatal overdoses were reduced in the three years after the legislation. Large overdoses were reduced by 20% (9% to 29%) for paracetamol and by 39% (14% to 57%) for salicylates in the second and third years after the legislation. Ibuprofen overdoses increased after the legislation, but with little or no effect on deaths. Conclusion Legislation restricting pack sizes of analgesics in the United Kingdom has been beneficial. A further reduction in pack sizes could prevent more deaths.
Bibliography:PMID:15516343
istex:6984FE169F410F86C2FC9AA831444F26E629F354
ark:/67375/NVC-V52KKQ6N-1
Correspondence to: K Hawton
href:bmj-329-1076.pdf
local:bmj;329/7474/1076
ArticleID:bmj.38253.572581.7C
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Funding: Grant from Southeast Region Research and Development Committee.
Ethical approval: Not required
Sales data for paracetamol, salicylates, and ibuprofen are on bmj.com
Contributors: KH, SS, and JD designed the study. KH and SS coordinated the study and wrote the report with JD, with the help of the other investigators. JC, AJ, KW, MA, WB, BG, MH, DS, and KS participated in the planning, data collection, and writing of the report. JD conducted the data analysis. KH is the guarantor.
Competing interests: None declared.
Correspondence to: K Hawton keith.hawton@psych.ox.ac.uk
We thank for their support of the project: James Neuberger (Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham), Mervyn Davies (Department of Hepatology, St James's University Hospital, Leeds), AK Burroughs (Liver Transplantation and Hepatobiliary Unit, Royal Free Hospital, London), Julia Wendon (Liver Unit, King's College Hospital, London), OFW James (School of Clinical Medical Sciences, University of Newcastle), Kirsty Marin and Janice Davidson (Department of Medicine, University of Edinburgh, Royal Infirmary), A Clayton (Derbyshire Royal Infirmary) and Louis Appleby (Centre for Suicide Prevention, Manchester); and for their help and provision of data: Hugh McGlynn (Intercontinental Medical Statistics Health) and Clare Griffiths (Office for National Statistics).
ISSN:0959-8138
0959-8146
1468-5833
1756-1833
DOI:10.1136/bmj.38253.572581.7C